Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7494 USD | -32.49% | -30.61% | -46.47% |
08/05 | Transcript : Seres Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Seres Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.47% | 113M | |
+2.93% | 108B | |
-2.65% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Oppenheimer Adjusts Seres Therapeutics Price Target to $13 From $16, Maintains Outperform Rating